Manuscript Writing Service
International Journal of Dermatology, Venereology and Leprosy Sciences

2024, Vol. 7, Issue 2, Part A

Autologous micrografts from scalp tissue in treatment of androgenetic alopecia
Author(s)
Mai Ahmed Assem Reyad Mohammed, Noha Nabil Doghaim, Amal Ahmed El-Ashmawy, Dareen Abd-Alziz Mohammed and Soha Abdallah Hawwam
Abstract
Androgenetic alopecia (AGA) is a prevalent hair loss condition affecting both genders, characterized by progressive hair follicle miniaturization and a decline in hair density and thickness. This condition impacts quality of life and is associated with psychological issues such as depression and anxiety. Current treatments include FDA-approved finasteride and minoxidil, alongside various other approaches like dutasteride and hair transplantation. Emerging therapies focus on hair follicle stem cells (HFSCs), which, despite their presence in balding scalps, exhibit reduced proliferative activity. Techniques using autologous cellular micrografts, which involve mechanical isolation of HFSCs from scalp biopsies, have shown promise in enhancing hair density and thickness. These micrografts, derived from the patient's own cells, offer a minimally invasive and effective solution for AGA, potentially reducing the need for ongoing treatments and mitigating patient non-compliance.
Pages: 16-21 | Views: 316 | Downloads: 125


International Journal of Dermatology, Venereology and Leprosy Sciences
How to cite this article:
Mai Ahmed Assem Reyad Mohammed, Noha Nabil Doghaim, Amal Ahmed El-Ashmawy, Dareen Abd-Alziz Mohammed, Soha Abdallah Hawwam. Autologous micrografts from scalp tissue in treatment of androgenetic alopecia. Int J Dermatol Venereology Leprosy Sci 2024;7(2):16-21. DOI: 10.33545/26649411.2024.v7.i2a.187
International Journal of Dermatology, Venereology and Leprosy Sciences
Call for book chapter